Literature DB >> 15467447

The life cycle of C-myc: from synthesis to degradation.

Rosalie C Sears1.   

Abstract

The c-Myc transcription factor is a potent regulator of cellular proliferation and cell fate decision. Precise regulation of c-Myc protein levels is essential to maintain normal cell function. In order to maintain proper levels of c-Myc, its protein stability is tightly controlled. c-Myc is degraded through the ubiquitin-proteasome pathway. This perspective discusses a sophisticated and complex signaling pathway that controls the life cycle of c-Myc from protein synthesis to ubiquitin-mediated degradation. The pathway involves Ras-activated kinases, the Pin1 prolyl isomerase, the PP2A phosphatase and a series of c-Myc phosphorylation and dephosphorylation events that control its stability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467447

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  151 in total

1.  Transformation by E1A oncoprotein involves ubiquitin-mediated proteolysis of the neuronal and tumor repressor REST in the nucleus.

Authors:  Hancheng Guan; Robert P Ricciardi
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

2.  Deubiquitinating c-Myc: USP36 steps up in the nucleolus.

Authors:  Xiao-Xin Sun; Rosalie C Sears; Mu-Shui Dai
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  PLK1: a promising and previously unexplored target in double-hit lymphoma.

Authors:  Quais N Hassan; Lapo Alinari; John C Byrd
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

4.  Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.

Authors:  Darya V Urusova; Jung-Hyun Shim; Dong Joon Kim; Sung Keun Jung; Tatyana A Zykova; Andria Carper; Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-12

5.  Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.

Authors:  Simone Buraschi; Nutan Pal; Nadia Tyler-Rubinstein; Rick T Owens; Thomas Neill; Renato V Iozzo
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

Review 6.  Control of vertebrate development by MYC.

Authors:  Peter J Hurlin
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

7.  Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.

Authors:  Carmela Ciccarelli; Agnese Di Rocco; Giovanni Luca Gravina; Annunziata Mauro; Claudio Festuccia; Andrea Del Fattore; Paolo Berardinelli; Francesca De Felice; Daniela Musio; Marina Bouché; Vincenzo Tombolini; Bianca Maria Zani; Francesco Marampon
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-29       Impact factor: 4.553

8.  Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Robert B Jenkins; Fusheng Lan; Chi Van Dang; Jessica L Hicks; James Morgan; Toby C Cornish; Siobhan Sutcliffe; William B Isaacs; Jun Luo; Angelo M De Marzo
Journal:  Mod Pathol       Date:  2008-06-20       Impact factor: 7.842

Review 9.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

Review 10.  Polygenic susceptibility to breast cancer: current state-of-the-art.

Authors:  Maya Ghoussaini; Paul D P Pharoah
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.